You are here: Industry Insights > WuXi AppTec

News List

WuXi AppTec Named One of MIT Technology Review's 50 Smartest Companies prnasia
July 02, 2019
WuXi AppTec Named One of MIT Technology Review's 50 Smartest Companies.
China's WuXi AppTec buys up U.S. Pharmapace, boosting biometrics offering fiercepharma
May 12, 2019
With this buy, financial details of which are not being shared, WuXi Clinical boosts its biometrics capabilities in the U.S. and Europe.
WuXi AppTec to enhance biometrics services for clinical development biospectrumasia
May 06, 2019
Pharmapace will become a wholly-owned subsidiary of WuXi Clinical
WuXi AppTec hires cancer drug development vet as new CMO fiercepharma
April 14, 2019
WuXi AppTec has hired Frederick Hausheer, M.D., as its new chief medical officer as it looks to mine his clinical trial expertise for its boosted drug development offerings.
WuXi AppTec Appoints CMO contractpharma
April 09, 2019
WuXi AppTec Appoints CMO
WuXi AppTec eyes acquisitions after $1bn Hong Kong, S.A.R., China IPO pharmaphorum
December 17, 2018
Chinese biotech WuXi AppTec has completed its listing on Hong Kong, S.A.R., China’s HKEX, raising $967m just months after making its debut on the Shanghai exchange.
WuXi AppTec opens new medical device testing centre in Suzhou biospectrum
November 19, 2018
WuXi AppTec's Laboratory Testing Division provides a world-class, globally integrated testing solution for drug and medical device development and manufacturing
WuXi AppTec and Cyclica to collaborate on drug discovery efforts fiercebiotech
August 23, 2018
WuXi AppTec’s research service division and Canadian biotech Cyclica announced a partnershipto develop programs looking into the development of small molecule polypharmacology.
WuXi STA and Antengene sign development and manufacturing agreement cphi-online
July 25, 2018
WuXi STA chosen for its end-to-end CMC platform for new drug development.
WuXi AppTec, Insilico unite to integrate AI with Drug Discovery biospectrumasia
June 13, 2018
WuXi AppTec and Insilico Medicine establish a close strategic collaboration to integrate next-generation artificial intelligence with drug discovery

Previous page 1 2 3 Next page